Armata Pharmaceuticals, Inc. Common Stock (ARMP)
CapEx to Revenue
0.68%
Quarterly · Period ending:
ARMP CapEx to Revenue
Latest reported0.68%period ending
Latest reported0.68%period ending
ARMP Quarterly CapEx/Revenue (0.00% → 0.68%)
Latest values, visible window
High-resolution chart · PNG
ARMP capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.6773% | |
| 7.9848% | |
| 0% | |
| 0% | |
| 6.8695% | |
| 20.1629% | |
| 6.2348% | |
| 11.4363% | |
| 0% | |
| 25.8799% | |
| 157.0681% | |
| 286.6939% | |
| 22.6531% | |
| 252.5126% | |
| 43.2921% | |
| 96.7115% | |
| 60.3293% | |
| 19.0939% | |
| 23.0536% | |
| 46.5228% | |
| 16.7808% | |
| 27.955% | |
| 72.619% | |
| 28.125% | |
| 880.6452% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 90% | |
| 86.8421% | |
| 7.1429% | |
| 17.2414% | |
| 59.0909% | |
| 100% | |
| 121.3592% | |
| 105.6604% | |
| 39.0625% | |
| 81.1189% | |
| 8.8235% | |
| 34.3137% | |
| 114.1414% | |
| 28.1553% | |
| 268.0645% | |
| 220.1923% | |
| -62.5% | |
| -1,066.6667% | |
| 20.7006% | |
| 0% | |
| 0% | |
| 0.1487% | |
| 0.2969% | |
| 4.4196% | |
| 6.2572% | |
| 22.1726% | |
| 1.3605% | |
| 6.8634% | |
| 3.684% | |
| 0% | |
| 0% | |
| 0.2246% | |
| 0.7455% | |
| 1.768% | |
| 1.3169% | |
| 2.6235% | |
| 21.5259% | |
| 8.3447% | |
| 9% | |
| 1.9478% | |
| 8.7521% | |
| 1.9196% | |
| 6.3636% | |
| 12.1102% | |
| 0.6198% | |
| 4.189% | |
| 0.5675% | |
| 1.5172% | |
| 3.0278% | |
| 5.3342% | |
| 4.4879% | |
| 9.7205% | |
| 3.7256% | |
| 55.8378% | |
| 44.3955% | |
| 176.3932% | |
| 6.485% | |
| 1.4856% | |
| 16.6816% | |
| 17.8571% | |
| 28.5714% | |
| 33.3333% | |
| 38.4615% | |
| 0% | |
| 100% | |
| 0% |